Ajanta Pharma gets USFDA approval for Ranitidine HCL

The market for Ranitidine HCL, in both the strengths, is likely to be less than $100mn and we expect this to be a small drug for Ajanta Pharma.

from India Infoline News Service https://ift.tt/2P1NHSf